890 related articles for article (PubMed ID: 18358930)
1. Acute lymphoblastic leukaemia.
Pui CH; Robison LL; Look AT
Lancet; 2008 Mar; 371(9617):1030-43. PubMed ID: 18358930
[TBL] [Abstract][Full Text] [Related]
2. [A brief history of treatments for childhood acute lymphoblastic leukaemia].
Leverger G; Baruchel A; Schaison G
Bull Acad Natl Med; 2009 Oct; 193(7):1495-9; discussion 1499-500. PubMed ID: 20669630
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia.
Rubnitz JE; Pui CH
Cancer Treat Rev; 2003 Feb; 29(1):31-44. PubMed ID: 12633578
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
Pui CH; Jeha S
Nat Rev Drug Discov; 2007 Feb; 6(2):149-65. PubMed ID: 17268486
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukaemia.
Inaba H; Greaves M; Mullighan CG
Lancet; 2013 Jun; 381(9881):1943-55. PubMed ID: 23523389
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
7. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.
Hjalgrim LL; Madsen HO; Melbye M; Jørgensen P; Christiansen M; Andersen MT; Pallisgaard N; Hokland P; Clausen N; Ryder LP; Schmiegelow K; Hjalgrim H
Br J Cancer; 2002 Oct; 87(9):994-9. PubMed ID: 12434291
[TBL] [Abstract][Full Text] [Related]
8. The role of anthracyclines in adult acute lymphoblastic leukaemia.
Bassan R; Lerede T; Rambaldi A; Di Bona E; Rossi G; Pogliani E; Lambertenghi-Deliliers G; Porcellini A; Fabris P; Barbui T
Leukemia; 1996 Jun; 10 Suppl 2():s58-61. PubMed ID: 8649053
[TBL] [Abstract][Full Text] [Related]
9. Relapsed childhood acute lymphoblastic leukaemia.
Bhojwani D; Pui CH
Lancet Oncol; 2013 May; 14(6):e205-17. PubMed ID: 23639321
[TBL] [Abstract][Full Text] [Related]
10. Childhood acute lymphoblastic leukaemia--current status and future perspectives.
Pui CH; Campana D; Evans WE
Lancet Oncol; 2001 Oct; 2(10):597-607. PubMed ID: 11902549
[TBL] [Abstract][Full Text] [Related]
11. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia.
Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonmundsson G; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
Leukemia; 2005 Jan; 19(1):165-9. PubMed ID: 15526029
[No Abstract] [Full Text] [Related]
12. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
Cheok MH; Evans WE
Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
[TBL] [Abstract][Full Text] [Related]
13. Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapy.
Ziegler DS; Dalla Pozza L; Waters KD; Marshall GM
Med J Aust; 2005 Jan; 182(2):78-81. PubMed ID: 15651967
[TBL] [Abstract][Full Text] [Related]
14. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?
Plasschaert SL; Kamps WA; Vellenga E; de Vries EG; de Bont ES
Cancer Treat Rev; 2004 Feb; 30(1):37-51. PubMed ID: 14766125
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.
Eckert C; Biondi A; Seeger K; Cazzaniga G; Hartmann R; Beyermann B; Pogodda M; Proba J; Henze G
Lancet; 2001 Oct; 358(9289):1239-41. PubMed ID: 11675066
[TBL] [Abstract][Full Text] [Related]
16. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
17. Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents.
Sonnemann J; Gruhn B; Wittig S; Becker S; Beck JF
Br J Haematol; 2012 Sep; 158(5):664-6. PubMed ID: 22686282
[No Abstract] [Full Text] [Related]
18. Relapse as acute monocytic leukaemia of acute lymphoblastic leukaemia with t(4;11).
Daniel MT; Jonveaux P; Berger R
Nouv Rev Fr Hematol (1978); 1992; 34(4):347-8. PubMed ID: 1448357
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
Badowska W
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in acute lymphoblastic leukemia.
Cheok MH; Pottier N; Kager L; Evans WE
Semin Hematol; 2009 Jan; 46(1):39-51. PubMed ID: 19100367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
